U.S. Induced Pluripotent Stem Cells (iPSCs) Market – Industry Trends and Forecast to 2031

U.S. Induced Pluripotent Stem Cells (iPSCs) Market, By Model Type (ECM-Patterned PAA/ PDMS Substrates, Microgroove PDMS Substrates, Strained Membranes, 3D Sacffolds, Free-Floating Hydrogel Contructs, and EHTS), Material (Natural Hydrogel-Based Cardiac Models and Synthetic Fibrous Cardiac Models), Cell Source (Skin Cells and Blood Cells), Dimensional Type (2D and 3D), Application (Production of New Cardiac Tissue to Replace Tissue Destroyed by Infraction or Other Diseases, Heart Failure, Ischemic Heart Disease, Arrhythmia, Cardiomyopathies, Valvular Heart Disease, Heart Disease Screening, and Others), End Use (Pharmaceutical & Biotechnology Companies, Academic and Government Research Institutes, Contract Development & Manufacturing Organizations, and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2031.

美国诱导多能干细胞（iPSCs）市场，按模型类型（ECM-图案化PAA/ PDMS基板、微沟槽PDMS基板、应力膜、3D支架、自由悬浮水凝胶结构以及EHTS）、材料（基于天然水凝胶的心脏模型和合成纤维心脏模型）、细胞来源（皮肤细胞和血液细胞）、维度类型（二维和三维）、应用（生产新型心脏组织以替代由梗塞或其他疾病破坏的组织、心力衰竭、缺血性心脏病、心律失常、心肌病、瓣膜性心脏病、心脏病筛查以及其他）、终端用途（制药与生物技术公司、学术和政府研究机构、合同开发与制造组织以及其他）、分销渠道（直接投标和零售销售）——行业趋势与预测至2031年。